elosulfase alfa for morquio a syndrome Companies
-
based in San Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
Vimizim - Model MPS IVA - Elosulfase Alfa for Morquio A Syndrome
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) ...
REQUEST QUOTEEstablished in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you